Non-segmental Vitiligo Clinical Trial
Official title:
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants With Non-Segmental Vitiligo
The purpose of this study is to evaluate the efficacy, safety, and tolerability of MK-6194 in participants with non-segmental vitiligo. The primary hypothesis is that at least 1 MK-6194 dose is superior to placebo with regards to percent change from baseline in Facial Vitiligo Area Scoring Index (F-VASI) at Week 24.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04052425 -
Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)
|
Phase 3 | |
| Completed |
NCT04057573 -
Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)
|
Phase 3 | |
| Completed |
NCT04942860 -
The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo
|
Phase 3 | |
| Recruiting |
NCT01377077 -
Punchgrafting Techniques for Vitiligo
|
Phase 4 | |
| Completed |
NCT04927975 -
Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo
|
Phase 2 | |
| Completed |
NCT04487860 -
Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo
|
Phase 2 | |
| Active, not recruiting |
NCT04811326 -
Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation
|
Phase 4 | |
| Terminated |
NCT03022019 -
ReNovaCell in Non-segmental Vitiligo
|
N/A | |
| Completed |
NCT03247400 -
The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05990309 -
ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO
|
N/A |